nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR8—decidua—ovarian cancer	0.0272	0.156	CbGeAlD
Imiquimod—CYP3A4—Topotecan—ovarian cancer	0.0219	0.354	CbGbCtD
Imiquimod—TLR8—female reproductive system—ovarian cancer	0.0214	0.122	CbGeAlD
Imiquimod—TLR8—bone marrow—ovarian cancer	0.0202	0.116	CbGeAlD
Imiquimod—TLR7—decidua—ovarian cancer	0.0172	0.0981	CbGeAlD
Imiquimod—CYP3A4—Vinorelbine—ovarian cancer	0.0154	0.249	CbGbCtD
Imiquimod—TLR7—gonad—ovarian cancer	0.0151	0.0864	CbGeAlD
Imiquimod—TLR7—uterus—ovarian cancer	0.015	0.0859	CbGeAlD
Imiquimod—TLR7—female reproductive system—ovarian cancer	0.0135	0.0772	CbGeAlD
Imiquimod—TLR8—lymph node—ovarian cancer	0.0125	0.0716	CbGeAlD
Imiquimod—TLR7—vagina—ovarian cancer	0.0122	0.0698	CbGeAlD
Imiquimod—TLR7—testis—ovarian cancer	0.0109	0.0623	CbGeAlD
Imiquimod—CYP3A4—Paclitaxel—ovarian cancer	0.0108	0.175	CbGbCtD
Imiquimod—TLR7—lymph node—ovarian cancer	0.0079	0.0451	CbGeAlD
Imiquimod—CYP3A4—Docetaxel—ovarian cancer	0.00784	0.127	CbGbCtD
Imiquimod—CYP3A4—Doxorubicin—ovarian cancer	0.00584	0.0945	CbGbCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CG—ovarian cancer	0.00184	0.00754	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—PIK3CB—ovarian cancer	0.00181	0.0074	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CG—ovarian cancer	0.00179	0.00732	CbGpPWpGaD
Imiquimod—CYP3A4—female reproductive system—ovarian cancer	0.00176	0.0101	CbGeAlD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CXCL8—ovarian cancer	0.00174	0.00711	CbGpPWpGaD
Imiquimod—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.00165	0.00675	CbGpPWpGaD
Imiquimod—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.00163	0.00669	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CD—ovarian cancer	0.00162	0.00663	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.00158	0.00645	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CD—ovarian cancer	0.00157	0.00643	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK3—ovarian cancer	0.00153	0.00626	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—ovarian cancer	0.00152	0.0062	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—MAPK3—ovarian cancer	0.0015	0.00615	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TLR4—ovarian cancer	0.0015	0.00613	CbGpPWpGaD
Imiquimod—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00148	0.00605	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—ovarian cancer	0.00146	0.00596	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—MAPK3—ovarian cancer	0.00145	0.00593	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6ST—ovarian cancer	0.00144	0.00588	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—MAPK1—ovarian cancer	0.00143	0.00585	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CB—ovarian cancer	0.00141	0.00578	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CG—ovarian cancer	0.0014	0.00571	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—ovarian cancer	0.00138	0.00565	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CB—ovarian cancer	0.00137	0.00561	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CXCL8—ovarian cancer	0.00136	0.00555	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—MAPK3—ovarian cancer	0.00134	0.00546	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—ovarian cancer	0.00132	0.00539	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—MAPK1—ovarian cancer	0.00127	0.0052	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—EREG—ovarian cancer	0.00125	0.0051	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IKBKG—ovarian cancer	0.00125	0.0051	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CD—ovarian cancer	0.00123	0.00502	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.00122	0.00498	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK3—ovarian cancer	0.00116	0.00475	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—MAPK3—ovarian cancer	0.00114	0.00466	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—ovarian cancer	0.00112	0.00458	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—ovarian cancer	0.0011	0.00452	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—PIK3CA—ovarian cancer	0.0011	0.00451	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—MAPK3—ovarian cancer	0.0011	0.0045	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—ovarian cancer	0.0011	0.0045	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—MAPK1—ovarian cancer	0.00108	0.00443	CbGpPWpGaD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00108	0.0044	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CB—ovarian cancer	0.00107	0.00438	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—ovarian cancer	0.00106	0.00434	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—ovarian cancer	0.00105	0.00428	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—MAPK3—ovarian cancer	0.00104	0.00427	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—MAPK3—ovarian cancer	0.00103	0.00422	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—ovarian cancer	0.00103	0.00421	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—MAPK3—ovarian cancer	0.00101	0.00414	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—MAPK1—ovarian cancer	0.000992	0.00406	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.000991	0.00405	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—MAPK1—ovarian cancer	0.000981	0.00401	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—ovarian cancer	0.000976	0.00399	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PVRL2—ovarian cancer	0.000971	0.00397	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—MAPK1—ovarian cancer	0.000963	0.00394	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IKBKG—ovarian cancer	0.000946	0.00387	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EREG—ovarian cancer	0.000946	0.00387	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000939	0.00384	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—AKT1—ovarian cancer	0.000901	0.00369	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PPP2R1A—ovarian cancer	0.000882	0.00361	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CA—ovarian cancer	0.000861	0.00352	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—ovarian cancer	0.000848	0.00347	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—ovarian cancer	0.000836	0.00342	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—ovarian cancer	0.000833	0.00341	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.00083	0.0034	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00083	0.00339	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PARK2—ovarian cancer	0.000829	0.00339	CbGpPWpGaD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000809	0.00331	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—ovarian cancer	0.000804	0.00329	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—MAPK3—ovarian cancer	0.00079	0.00323	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—MAPK3—ovarian cancer	0.000781	0.0032	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—ovarian cancer	0.000762	0.00312	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—ovarian cancer	0.000754	0.00308	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—MAPK1—ovarian cancer	0.000752	0.00308	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—MAPK1—ovarian cancer	0.000743	0.00304	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—ovarian cancer	0.00074	0.00303	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PVRL2—ovarian cancer	0.000736	0.00301	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EREG—ovarian cancer	0.000727	0.00297	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IKBKG—ovarian cancer	0.000727	0.00297	CbGpPWpGaD
Imiquimod—TLR8—Immune System—SKP2—ovarian cancer	0.00071	0.00291	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—AKT1—ovarian cancer	0.000703	0.00288	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—AKT1—ovarian cancer	0.000683	0.00279	CbGpPWpGaD
Imiquimod—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000681	0.00279	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PPP2R1A—ovarian cancer	0.000668	0.00273	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—ovarian cancer	0.000652	0.00267	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TLR4—ovarian cancer	0.000641	0.00262	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PARK2—ovarian cancer	0.000628	0.00257	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6ST—ovarian cancer	0.000614	0.00251	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000602	0.00246	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—ovarian cancer	0.000578	0.00236	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.000574	0.00235	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.000574	0.00235	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000574	0.00235	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—ovarian cancer	0.000571	0.00234	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.000555	0.00227	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IKBKG—ovarian cancer	0.000551	0.00225	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EREG—ovarian cancer	0.000551	0.00225	CbGpPWpGaD
Imiquimod—TLR7—Immune System—SKP2—ovarian cancer	0.000538	0.0022	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000537	0.0022	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—ovarian cancer	0.000533	0.00218	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PIK3CD—ovarian cancer	0.000519	0.00212	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PPP2R1A—ovarian cancer	0.000514	0.0021	CbGpPWpGaD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000488	0.002	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TLR4—ovarian cancer	0.000486	0.00199	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6ST—ovarian cancer	0.000466	0.0019	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000465	0.0019	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000464	0.0019	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ERBB2—ovarian cancer	0.000458	0.00187	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000458	0.00187	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD8A—ovarian cancer	0.000458	0.00187	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PIK3CB—ovarian cancer	0.000452	0.00185	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MTOR—ovarian cancer	0.000452	0.00185	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000443	0.00181	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CDKN1B—ovarian cancer	0.000424	0.00174	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CTNNB1—ovarian cancer	0.000401	0.00164	CbGpPWpGaD
Imiquimod—Infection—Paclitaxel—ovarian cancer	0.000398	0.000768	CcSEcCtD
Imiquimod—Shock—Paclitaxel—ovarian cancer	0.000394	0.000761	CcSEcCtD
Imiquimod—Dizziness—Vinorelbine—ovarian cancer	0.000394	0.00076	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PIK3CD—ovarian cancer	0.000393	0.00161	CbGpPWpGaD
Imiquimod—Nervous system disorder—Paclitaxel—ovarian cancer	0.000393	0.000758	CcSEcCtD
Imiquimod—Tachycardia—Paclitaxel—ovarian cancer	0.000391	0.000754	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PTEN—ovarian cancer	0.000391	0.0016	CbGpPWpGaD
Imiquimod—Breast disorder—Doxorubicin—ovarian cancer	0.00039	0.000752	CcSEcCtD
Imiquimod—Skin disorder—Paclitaxel—ovarian cancer	0.000389	0.000751	CcSEcCtD
Imiquimod—TLR7—Immune System—PPP2R1A—ovarian cancer	0.000389	0.00159	CbGpPWpGaD
Imiquimod—Bronchitis—Epirubicin—ovarian cancer	0.000388	0.000747	CcSEcCtD
Imiquimod—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000388	0.000747	CcSEcCtD
Imiquimod—Pancytopenia—Epirubicin—ovarian cancer	0.000383	0.000738	CcSEcCtD
Imiquimod—Anorexia—Paclitaxel—ovarian cancer	0.000382	0.000737	CcSEcCtD
Imiquimod—Vomiting—Vinorelbine—ovarian cancer	0.000379	0.000731	CcSEcCtD
Imiquimod—Dysuria—Epirubicin—ovarian cancer	0.000377	0.000727	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000376	0.00154	CbGpPWpGaD
Imiquimod—Rash—Vinorelbine—ovarian cancer	0.000376	0.000725	CcSEcCtD
Imiquimod—Dermatitis—Vinorelbine—ovarian cancer	0.000375	0.000724	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000375	0.000722	CcSEcCtD
Imiquimod—Headache—Vinorelbine—ovarian cancer	0.000373	0.00072	CcSEcCtD
Imiquimod—Syncope—Docetaxel—ovarian cancer	0.000373	0.00072	CcSEcCtD
Imiquimod—TLR8—Immune System—TLR4—ovarian cancer	0.000373	0.00153	CbGpPWpGaD
Imiquimod—Influenza—Doxorubicin—ovarian cancer	0.000373	0.000719	CcSEcCtD
Imiquimod—Palpitations—Docetaxel—ovarian cancer	0.000368	0.000709	CcSEcCtD
Imiquimod—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000368	0.000709	CcSEcCtD
Imiquimod—Loss of consciousness—Docetaxel—ovarian cancer	0.000366	0.000706	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000365	0.000704	CcSEcCtD
Imiquimod—Cough—Docetaxel—ovarian cancer	0.000363	0.000701	CcSEcCtD
Imiquimod—Insomnia—Paclitaxel—ovarian cancer	0.000363	0.000699	CcSEcCtD
Imiquimod—Convulsion—Docetaxel—ovarian cancer	0.000361	0.000696	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.000361	0.00147	CbGpPWpGaD
Imiquimod—Paraesthesia—Paclitaxel—ovarian cancer	0.00036	0.000694	CcSEcCtD
Imiquimod—Hypertension—Docetaxel—ovarian cancer	0.000359	0.000693	CcSEcCtD
Imiquimod—Infestation NOS—Epirubicin—ovarian cancer	0.000359	0.000693	CcSEcCtD
Imiquimod—Infestation—Epirubicin—ovarian cancer	0.000359	0.000693	CcSEcCtD
Imiquimod—Bronchitis—Doxorubicin—ovarian cancer	0.000359	0.000692	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000358	0.00147	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6ST—ovarian cancer	0.000358	0.00146	CbGpPWpGaD
Imiquimod—Dyspnoea—Paclitaxel—ovarian cancer	0.000357	0.000689	CcSEcCtD
Imiquimod—Somnolence—Paclitaxel—ovarian cancer	0.000356	0.000687	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000356	0.000687	CcSEcCtD
Imiquimod—Chest pain—Docetaxel—ovarian cancer	0.000354	0.000683	CcSEcCtD
Imiquimod—Myalgia—Docetaxel—ovarian cancer	0.000354	0.000683	CcSEcCtD
Imiquimod—Arthralgia—Docetaxel—ovarian cancer	0.000354	0.000683	CcSEcCtD
Imiquimod—Pancytopenia—Doxorubicin—ovarian cancer	0.000354	0.000683	CcSEcCtD
Imiquimod—Nausea—Vinorelbine—ovarian cancer	0.000354	0.000683	CcSEcCtD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000354	0.00145	CbGpPWpGaD
Imiquimod—Dyspepsia—Paclitaxel—ovarian cancer	0.000353	0.00068	CcSEcCtD
Imiquimod—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000352	0.000679	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000352	0.000679	CcSEcCtD
Imiquimod—Conjunctivitis—Epirubicin—ovarian cancer	0.000349	0.000674	CcSEcCtD
Imiquimod—Urinary tract infection—Epirubicin—ovarian cancer	0.000349	0.000674	CcSEcCtD
Imiquimod—Dysuria—Doxorubicin—ovarian cancer	0.000349	0.000672	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—NRAS—ovarian cancer	0.000349	0.00143	CbGpPWpGaD
Imiquimod—Decreased appetite—Paclitaxel—ovarian cancer	0.000348	0.000672	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—ERBB2—ovarian cancer	0.000347	0.00142	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD8A—ovarian cancer	0.000347	0.00142	CbGpPWpGaD
Imiquimod—Dry mouth—Docetaxel—ovarian cancer	0.000347	0.000668	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000347	0.000668	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000346	0.000667	CcSEcCtD
Imiquimod—Fatigue—Paclitaxel—ovarian cancer	0.000346	0.000666	CcSEcCtD
Imiquimod—Pain—Paclitaxel—ovarian cancer	0.000343	0.000661	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—MTOR—ovarian cancer	0.000343	0.0014	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PIK3CB—ovarian cancer	0.000343	0.0014	CbGpPWpGaD
Imiquimod—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00034	0.000656	CcSEcCtD
Imiquimod—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00034	0.000655	CcSEcCtD
Imiquimod—Oedema—Docetaxel—ovarian cancer	0.00034	0.000655	CcSEcCtD
Imiquimod—Infection—Docetaxel—ovarian cancer	0.000338	0.000651	CcSEcCtD
Imiquimod—Sinusitis—Epirubicin—ovarian cancer	0.000337	0.00065	CcSEcCtD
Imiquimod—Shock—Docetaxel—ovarian cancer	0.000334	0.000645	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—MAPK3—ovarian cancer	0.000334	0.00137	CbGpPWpGaD
Imiquimod—Nervous system disorder—Docetaxel—ovarian cancer	0.000333	0.000643	CcSEcCtD
Imiquimod—Infestation NOS—Doxorubicin—ovarian cancer	0.000333	0.000641	CcSEcCtD
Imiquimod—Infestation—Doxorubicin—ovarian cancer	0.000333	0.000641	CcSEcCtD
Imiquimod—Tachycardia—Docetaxel—ovarian cancer	0.000332	0.000639	CcSEcCtD
Imiquimod—Feeling abnormal—Paclitaxel—ovarian cancer	0.00033	0.000637	CcSEcCtD
Imiquimod—Skin disorder—Docetaxel—ovarian cancer	0.00033	0.000636	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00033	0.000636	CcSEcCtD
Imiquimod—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000328	0.000632	CcSEcCtD
Imiquimod—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000326	0.000628	CcSEcCtD
Imiquimod—Haemoglobin—Epirubicin—ovarian cancer	0.000324	0.000625	CcSEcCtD
Imiquimod—Anorexia—Docetaxel—ovarian cancer	0.000324	0.000625	CcSEcCtD
Imiquimod—Rhinitis—Epirubicin—ovarian cancer	0.000323	0.000624	CcSEcCtD
Imiquimod—Conjunctivitis—Doxorubicin—ovarian cancer	0.000323	0.000623	CcSEcCtD
Imiquimod—Urinary tract infection—Doxorubicin—ovarian cancer	0.000323	0.000623	CcSEcCtD
Imiquimod—Haemorrhage—Epirubicin—ovarian cancer	0.000323	0.000622	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CDKN1B—ovarian cancer	0.000322	0.00132	CbGpPWpGaD
Imiquimod—Pharyngitis—Epirubicin—ovarian cancer	0.00032	0.000617	CcSEcCtD
Imiquimod—Urinary tract disorder—Epirubicin—ovarian cancer	0.000319	0.000614	CcSEcCtD
Imiquimod—Urticaria—Paclitaxel—ovarian cancer	0.000318	0.000614	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—MAPK1—ovarian cancer	0.000318	0.0013	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—EGFR—ovarian cancer	0.000318	0.0013	CbGpPWpGaD
Imiquimod—Connective tissue disorder—Epirubicin—ovarian cancer	0.000317	0.000611	CcSEcCtD
Imiquimod—Body temperature increased—Paclitaxel—ovarian cancer	0.000317	0.000611	CcSEcCtD
Imiquimod—Abdominal pain—Paclitaxel—ovarian cancer	0.000317	0.000611	CcSEcCtD
Imiquimod—TLR8—Immune System—CDH1—ovarian cancer	0.000316	0.00129	CbGpPWpGaD
Imiquimod—Urethral disorder—Epirubicin—ovarian cancer	0.000316	0.00061	CcSEcCtD
Imiquimod—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000314	0.000606	CcSEcCtD
Imiquimod—Sinusitis—Doxorubicin—ovarian cancer	0.000312	0.000602	CcSEcCtD
Imiquimod—Visual impairment—Epirubicin—ovarian cancer	0.000311	0.000599	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00031	0.000597	CcSEcCtD
Imiquimod—Insomnia—Docetaxel—ovarian cancer	0.000307	0.000593	CcSEcCtD
Imiquimod—Paraesthesia—Docetaxel—ovarian cancer	0.000305	0.000588	CcSEcCtD
Imiquimod—Erythema multiforme—Epirubicin—ovarian cancer	0.000305	0.000588	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CTNNB1—ovarian cancer	0.000304	0.00124	CbGpPWpGaD
Imiquimod—Dyspnoea—Docetaxel—ovarian cancer	0.000303	0.000584	CcSEcCtD
Imiquimod—TLR8—Immune System—PIK3CD—ovarian cancer	0.000302	0.00124	CbGpPWpGaD
Imiquimod—Somnolence—Docetaxel—ovarian cancer	0.000302	0.000582	CcSEcCtD
Imiquimod—Eye disorder—Epirubicin—ovarian cancer	0.000301	0.000581	CcSEcCtD
Imiquimod—Tinnitus—Epirubicin—ovarian cancer	0.000301	0.00058	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—KRAS—ovarian cancer	0.0003	0.00123	CbGpPWpGaD
Imiquimod—Haemoglobin—Doxorubicin—ovarian cancer	0.0003	0.000578	CcSEcCtD
Imiquimod—Flushing—Epirubicin—ovarian cancer	0.000299	0.000577	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—ovarian cancer	0.000299	0.000577	CcSEcCtD
Imiquimod—Dyspepsia—Docetaxel—ovarian cancer	0.000299	0.000577	CcSEcCtD
Imiquimod—Haemorrhage—Doxorubicin—ovarian cancer	0.000298	0.000576	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—ovarian cancer	0.000296	0.000571	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PTEN—ovarian cancer	0.000296	0.00121	CbGpPWpGaD
Imiquimod—Decreased appetite—Docetaxel—ovarian cancer	0.000295	0.00057	CcSEcCtD
Imiquimod—Hypersensitivity—Paclitaxel—ovarian cancer	0.000295	0.00057	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000295	0.000568	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000293	0.000566	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000293	0.000566	CcSEcCtD
Imiquimod—Fatigue—Docetaxel—ovarian cancer	0.000293	0.000565	CcSEcCtD
Imiquimod—Angiopathy—Epirubicin—ovarian cancer	0.000293	0.000564	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—ovarian cancer	0.000293	0.000564	CcSEcCtD
Imiquimod—Immune system disorder—Epirubicin—ovarian cancer	0.000291	0.000562	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—ovarian cancer	0.000291	0.000561	CcSEcCtD
Imiquimod—Pain—Docetaxel—ovarian cancer	0.000291	0.00056	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00029	0.00119	CbGpPWpGaD
Imiquimod—Chills—Epirubicin—ovarian cancer	0.000289	0.000558	CcSEcCtD
Imiquimod—Arrhythmia—Epirubicin—ovarian cancer	0.000288	0.000556	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—ovarian cancer	0.000288	0.000555	CcSEcCtD
Imiquimod—Asthenia—Paclitaxel—ovarian cancer	0.000288	0.000555	CcSEcCtD
Imiquimod—Alopecia—Epirubicin—ovarian cancer	0.000285	0.00055	CcSEcCtD
Imiquimod—Pruritus—Paclitaxel—ovarian cancer	0.000284	0.000547	CcSEcCtD
Imiquimod—TLR7—Immune System—TLR4—ovarian cancer	0.000283	0.00116	CbGpPWpGaD
Imiquimod—Mental disorder—Epirubicin—ovarian cancer	0.000283	0.000545	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—ovarian cancer	0.000282	0.000544	CcSEcCtD
Imiquimod—Malnutrition—Epirubicin—ovarian cancer	0.000281	0.000541	CcSEcCtD
Imiquimod—Erythema—Epirubicin—ovarian cancer	0.000281	0.000541	CcSEcCtD
Imiquimod—Feeling abnormal—Docetaxel—ovarian cancer	0.00028	0.00054	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—ovarian cancer	0.000279	0.000538	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—ovarian cancer	0.000278	0.000537	CcSEcCtD
Imiquimod—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000278	0.000536	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—ovarian cancer	0.000277	0.000534	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PIK3CA—ovarian cancer	0.000276	0.00113	CbGpPWpGaD
Imiquimod—Diarrhoea—Paclitaxel—ovarian cancer	0.000274	0.000529	CcSEcCtD
Imiquimod—Back pain—Epirubicin—ovarian cancer	0.000272	0.000524	CcSEcCtD
Imiquimod—TLR7—Immune System—IL6ST—ovarian cancer	0.000271	0.00111	CbGpPWpGaD
Imiquimod—Angiopathy—Doxorubicin—ovarian cancer	0.000271	0.000522	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—ovarian cancer	0.00027	0.00052	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000269	0.000519	CcSEcCtD
Imiquimod—Body temperature increased—Docetaxel—ovarian cancer	0.000269	0.000518	CcSEcCtD
Imiquimod—Abdominal pain—Docetaxel—ovarian cancer	0.000269	0.000518	CcSEcCtD
Imiquimod—Chills—Doxorubicin—ovarian cancer	0.000268	0.000516	CcSEcCtD
Imiquimod—TLR8—Immune System—ERBB2—ovarian cancer	0.000267	0.00109	CbGpPWpGaD
Imiquimod—Arrhythmia—Doxorubicin—ovarian cancer	0.000267	0.000514	CcSEcCtD
Imiquimod—Dizziness—Paclitaxel—ovarian cancer	0.000265	0.000511	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NRAS—ovarian cancer	0.000264	0.00108	CbGpPWpGaD
Imiquimod—Alopecia—Doxorubicin—ovarian cancer	0.000264	0.000509	CcSEcCtD
Imiquimod—TLR8—Immune System—PIK3CB—ovarian cancer	0.000263	0.00108	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MTOR—ovarian cancer	0.000263	0.00108	CbGpPWpGaD
Imiquimod—Mental disorder—Doxorubicin—ovarian cancer	0.000262	0.000504	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—ovarian cancer	0.000261	0.000502	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—ovarian cancer	0.00026	0.000501	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—ovarian cancer	0.00026	0.000501	CcSEcCtD
Imiquimod—Agitation—Epirubicin—ovarian cancer	0.000258	0.000498	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—HRAS—ovarian cancer	0.000255	0.00104	CbGpPWpGaD
Imiquimod—Vomiting—Paclitaxel—ovarian cancer	0.000255	0.000491	CcSEcCtD
Imiquimod—Malaise—Epirubicin—ovarian cancer	0.000253	0.000488	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—MAPK3—ovarian cancer	0.000253	0.00104	CbGpPWpGaD
Imiquimod—Rash—Paclitaxel—ovarian cancer	0.000253	0.000487	CcSEcCtD
Imiquimod—Dermatitis—Paclitaxel—ovarian cancer	0.000253	0.000487	CcSEcCtD
Imiquimod—Syncope—Epirubicin—ovarian cancer	0.000252	0.000486	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—ovarian cancer	0.000251	0.000485	CcSEcCtD
Imiquimod—Headache—Paclitaxel—ovarian cancer	0.000251	0.000484	CcSEcCtD
Imiquimod—Hypersensitivity—Docetaxel—ovarian cancer	0.00025	0.000483	CcSEcCtD
Imiquimod—Palpitations—Epirubicin—ovarian cancer	0.000248	0.000479	CcSEcCtD
Imiquimod—TLR8—Immune System—CDKN1B—ovarian cancer	0.000247	0.00101	CbGpPWpGaD
Imiquimod—Loss of consciousness—Epirubicin—ovarian cancer	0.000247	0.000476	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000245	0.001	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000245	0.001	CbGpPWpGaD
Imiquimod—Cough—Epirubicin—ovarian cancer	0.000245	0.000473	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—ovarian cancer	0.000244	0.000999	CbGpPWpGaD
Imiquimod—Asthenia—Docetaxel—ovarian cancer	0.000244	0.00047	CcSEcCtD
Imiquimod—Convulsion—Epirubicin—ovarian cancer	0.000243	0.000469	CcSEcCtD
Imiquimod—Hypertension—Epirubicin—ovarian cancer	0.000242	0.000468	CcSEcCtD
Imiquimod—TLR8—Immune System—IL2—ovarian cancer	0.000242	0.00099	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000241	0.000465	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—MAPK1—ovarian cancer	0.000241	0.000985	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EGFR—ovarian cancer	0.000241	0.000985	CbGpPWpGaD
Imiquimod—Pruritus—Docetaxel—ovarian cancer	0.00024	0.000464	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.00024	0.000981	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDH1—ovarian cancer	0.00024	0.000981	CbGpPWpGaD
Imiquimod—Myalgia—Epirubicin—ovarian cancer	0.000239	0.000461	CcSEcCtD
Imiquimod—Arthralgia—Epirubicin—ovarian cancer	0.000239	0.000461	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—ovarian cancer	0.000239	0.000461	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—ovarian cancer	0.000239	0.00046	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—ovarian cancer	0.000238	0.000459	CcSEcCtD
Imiquimod—Nausea—Paclitaxel—ovarian cancer	0.000238	0.000459	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000237	0.000458	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—ovarian cancer	0.000236	0.000455	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—ovarian cancer	0.000234	0.000452	CcSEcCtD
Imiquimod—Dry mouth—Epirubicin—ovarian cancer	0.000234	0.000451	CcSEcCtD
Imiquimod—TLR8—Immune System—CTNNB1—ovarian cancer	0.000234	0.000955	CbGpPWpGaD
Imiquimod—Syncope—Doxorubicin—ovarian cancer	0.000233	0.000449	CcSEcCtD
Imiquimod—Diarrhoea—Docetaxel—ovarian cancer	0.000232	0.000448	CcSEcCtD
Imiquimod—Palpitations—Doxorubicin—ovarian cancer	0.00023	0.000443	CcSEcCtD
Imiquimod—Oedema—Epirubicin—ovarian cancer	0.000229	0.000442	CcSEcCtD
Imiquimod—TLR7—Immune System—PIK3CD—ovarian cancer	0.000229	0.000937	CbGpPWpGaD
Imiquimod—Loss of consciousness—Doxorubicin—ovarian cancer	0.000228	0.00044	CcSEcCtD
Imiquimod—Infection—Epirubicin—ovarian cancer	0.000228	0.000439	CcSEcCtD
Imiquimod—TLR8—Immune System—PTEN—ovarian cancer	0.000228	0.000931	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—KRAS—ovarian cancer	0.000227	0.00093	CbGpPWpGaD
Imiquimod—Cough—Doxorubicin—ovarian cancer	0.000227	0.000437	CcSEcCtD
Imiquimod—Shock—Epirubicin—ovarian cancer	0.000225	0.000435	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—AKT1—ovarian cancer	0.000225	0.000921	CbGpPWpGaD
Imiquimod—Convulsion—Doxorubicin—ovarian cancer	0.000225	0.000434	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—ovarian cancer	0.000225	0.000433	CcSEcCtD
Imiquimod—Dizziness—Docetaxel—ovarian cancer	0.000225	0.000433	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—ovarian cancer	0.000224	0.000433	CcSEcCtD
Imiquimod—Tachycardia—Epirubicin—ovarian cancer	0.000224	0.000431	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—ovarian cancer	0.000223	0.000429	CcSEcCtD
Imiquimod—Hyperhidrosis—Epirubicin—ovarian cancer	0.000222	0.000427	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—ovarian cancer	0.000221	0.000427	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—ovarian cancer	0.000221	0.000427	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—ovarian cancer	0.000221	0.000427	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—ovarian cancer	0.00022	0.000425	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00022	0.000424	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—ovarian cancer	0.000219	0.000421	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—ovarian cancer	0.000218	0.000421	CcSEcCtD
Imiquimod—Dry mouth—Doxorubicin—ovarian cancer	0.000216	0.000417	CcSEcCtD
Imiquimod—Vomiting—Docetaxel—ovarian cancer	0.000216	0.000417	CcSEcCtD
Imiquimod—Rash—Docetaxel—ovarian cancer	0.000214	0.000413	CcSEcCtD
Imiquimod—Dermatitis—Docetaxel—ovarian cancer	0.000214	0.000413	CcSEcCtD
Imiquimod—Headache—Docetaxel—ovarian cancer	0.000213	0.00041	CcSEcCtD
Imiquimod—Oedema—Doxorubicin—ovarian cancer	0.000212	0.000409	CcSEcCtD
Imiquimod—Infection—Doxorubicin—ovarian cancer	0.000211	0.000406	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PIK3CA—ovarian cancer	0.000209	0.000855	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000209	0.000403	CcSEcCtD
Imiquimod—Shock—Doxorubicin—ovarian cancer	0.000209	0.000402	CcSEcCtD
Imiquimod—Nervous system disorder—Doxorubicin—ovarian cancer	0.000208	0.000401	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—ovarian cancer	0.000207	0.0004	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—ovarian cancer	0.000207	0.000399	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—ovarian cancer	0.000206	0.000397	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—ovarian cancer	0.000206	0.000397	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000205	0.000395	CcSEcCtD
Imiquimod—Dyspnoea—Epirubicin—ovarian cancer	0.000204	0.000394	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000204	0.000834	CbGpPWpGaD
Imiquimod—Somnolence—Epirubicin—ovarian cancer	0.000204	0.000393	CcSEcCtD
Imiquimod—TLR8—Immune System—STAT3—ovarian cancer	0.000204	0.000833	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NRAS—ovarian cancer	0.000203	0.000831	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ERBB2—ovarian cancer	0.000202	0.000828	CbGpPWpGaD
Imiquimod—Anorexia—Doxorubicin—ovarian cancer	0.000202	0.00039	CcSEcCtD
Imiquimod—Nausea—Docetaxel—ovarian cancer	0.000202	0.000389	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—ovarian cancer	0.000202	0.000389	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000201	0.000824	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.0002	0.000818	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MTOR—ovarian cancer	0.0002	0.000817	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3CB—ovarian cancer	0.0002	0.000817	CbGpPWpGaD
Imiquimod—Decreased appetite—Epirubicin—ovarian cancer	0.000199	0.000384	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000198	0.000382	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—ovarian cancer	0.000198	0.000381	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000197	0.000806	CbGpPWpGaD
Imiquimod—Pain—Epirubicin—ovarian cancer	0.000196	0.000378	CcSEcCtD
Imiquimod—TLR8—Immune System—MAPK3—ovarian cancer	0.000194	0.000796	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HRAS—ovarian cancer	0.000193	0.000791	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000193	0.000373	CcSEcCtD
Imiquimod—Insomnia—Doxorubicin—ovarian cancer	0.000192	0.00037	CcSEcCtD
Imiquimod—Paraesthesia—Doxorubicin—ovarian cancer	0.00019	0.000367	CcSEcCtD
Imiquimod—Dyspnoea—Doxorubicin—ovarian cancer	0.000189	0.000365	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—ovarian cancer	0.000189	0.000364	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—ovarian cancer	0.000189	0.000364	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000188	0.000767	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000187	0.000361	CcSEcCtD
Imiquimod—TLR7—Immune System—CDKN1B—ovarian cancer	0.000187	0.000766	CbGpPWpGaD
Imiquimod—Dyspepsia—Doxorubicin—ovarian cancer	0.000187	0.00036	CcSEcCtD
Imiquimod—TLR8—Immune System—MAPK1—ovarian cancer	0.000185	0.000757	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—ovarian cancer	0.000185	0.000757	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EGFR—ovarian cancer	0.000185	0.000757	CbGpPWpGaD
Imiquimod—Decreased appetite—Doxorubicin—ovarian cancer	0.000184	0.000355	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000183	0.00075	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000183	0.00075	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000183	0.00075	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL2—ovarian cancer	0.000183	0.00075	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000183	0.000353	CcSEcCtD
Imiquimod—Fatigue—Doxorubicin—ovarian cancer	0.000183	0.000353	CcSEcCtD
Imiquimod—Urticaria—Epirubicin—ovarian cancer	0.000182	0.000351	CcSEcCtD
Imiquimod—Pain—Doxorubicin—ovarian cancer	0.000181	0.00035	CcSEcCtD
Imiquimod—Abdominal pain—Epirubicin—ovarian cancer	0.000181	0.000349	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—ovarian cancer	0.000181	0.000349	CcSEcCtD
Imiquimod—TLR7—Immune System—CTNNB1—ovarian cancer	0.000177	0.000724	CbGpPWpGaD
Imiquimod—TLR8—Immune System—KRAS—ovarian cancer	0.000175	0.000715	CbGpPWpGaD
Imiquimod—Feeling abnormal—Doxorubicin—ovarian cancer	0.000175	0.000337	CcSEcCtD
Imiquimod—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000173	0.000334	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000173	0.000709	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTEN—ovarian cancer	0.000172	0.000706	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—ovarian cancer	0.000171	0.000698	CbGpPWpGaD
Imiquimod—Hypersensitivity—Epirubicin—ovarian cancer	0.000169	0.000326	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—ovarian cancer	0.000168	0.000325	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—ovarian cancer	0.000168	0.000323	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—ovarian cancer	0.000168	0.000323	CcSEcCtD
Imiquimod—Asthenia—Epirubicin—ovarian cancer	0.000164	0.000317	CcSEcCtD
Imiquimod—Pruritus—Epirubicin—ovarian cancer	0.000162	0.000313	CcSEcCtD
Imiquimod—TLR8—Immune System—PIK3CA—ovarian cancer	0.000161	0.000657	CbGpPWpGaD
Imiquimod—Diarrhoea—Epirubicin—ovarian cancer	0.000157	0.000302	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—ovarian cancer	0.000156	0.000301	CcSEcCtD
Imiquimod—TLR7—Immune System—STAT3—ovarian cancer	0.000154	0.000631	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000154	0.000631	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000154	0.000631	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NRAS—ovarian cancer	0.000154	0.00063	CbGpPWpGaD
Imiquimod—Asthenia—Doxorubicin—ovarian cancer	0.000152	0.000293	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000152	0.000622	CbGpPWpGaD
Imiquimod—Dizziness—Epirubicin—ovarian cancer	0.000152	0.000292	CcSEcCtD
Imiquimod—Pruritus—Doxorubicin—ovarian cancer	0.00015	0.000289	CcSEcCtD
Imiquimod—TLR8—Immune System—HRAS—ovarian cancer	0.000149	0.000608	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK3—ovarian cancer	0.000147	0.000603	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000147	0.000602	CbGpPWpGaD
Imiquimod—Vomiting—Epirubicin—ovarian cancer	0.000146	0.000281	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—ovarian cancer	0.000145	0.00028	CcSEcCtD
Imiquimod—Rash—Epirubicin—ovarian cancer	0.000145	0.000279	CcSEcCtD
Imiquimod—Dermatitis—Epirubicin—ovarian cancer	0.000144	0.000278	CcSEcCtD
Imiquimod—Headache—Epirubicin—ovarian cancer	0.000144	0.000277	CcSEcCtD
Imiquimod—TLR8—Immune System—IL6—ovarian cancer	0.000142	0.000582	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK1—ovarian cancer	0.00014	0.000574	CbGpPWpGaD
Imiquimod—Dizziness—Doxorubicin—ovarian cancer	0.00014	0.00027	CcSEcCtD
Imiquimod—TLR7—Immune System—EGFR—ovarian cancer	0.00014	0.000574	CbGpPWpGaD
Imiquimod—Nausea—Epirubicin—ovarian cancer	0.000136	0.000263	CcSEcCtD
Imiquimod—Vomiting—Doxorubicin—ovarian cancer	0.000135	0.00026	CcSEcCtD
Imiquimod—Rash—Doxorubicin—ovarian cancer	0.000134	0.000258	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—ovarian cancer	0.000134	0.000258	CcSEcCtD
Imiquimod—Headache—Doxorubicin—ovarian cancer	0.000133	0.000256	CcSEcCtD
Imiquimod—TLR7—Immune System—KRAS—ovarian cancer	0.000132	0.000542	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—ovarian cancer	0.000131	0.000537	CbGpPWpGaD
Imiquimod—Nausea—Doxorubicin—ovarian cancer	0.000126	0.000243	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—NME2—ovarian cancer	0.000122	0.000499	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3CA—ovarian cancer	0.000122	0.000498	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HRAS—ovarian cancer	0.000113	0.000461	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—ovarian cancer	0.000108	0.000441	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000103	0.000423	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—ovarian cancer	9.94e-05	0.000407	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NME2—ovarian cancer	9.41e-05	0.000385	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.43e-05	0.000345	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYTB—ovarian cancer	7.85e-05	0.000321	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.68e-05	0.000314	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BRIP1—ovarian cancer	6.86e-05	0.000281	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPP1CC—ovarian cancer	6.86e-05	0.000281	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYTB—ovarian cancer	6.06e-05	0.000248	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.3e-05	0.000217	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.3e-05	0.000217	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5e-05	0.000205	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—YAP1—ovarian cancer	4.6e-05	0.000188	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.56e-05	0.000186	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.01e-05	0.000164	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FASN—ovarian cancer	3.75e-05	0.000154	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC5A5—ovarian cancer	3.69e-05	0.000151	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.57e-05	0.000146	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—YAP1—ovarian cancer	3.55e-05	0.000145	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.49e-05	0.000143	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.42e-05	0.00014	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.03e-05	0.000124	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.02e-05	0.000123	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FASN—ovarian cancer	2.9e-05	0.000118	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.85e-05	0.000117	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.81e-05	0.000115	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TYMS—ovarian cancer	2.76e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.75e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.64e-05	0.000108	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.34e-05	9.57e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAV1—ovarian cancer	2.23e-05	9.11e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.17e-05	8.89e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TYMS—ovarian cancer	2.13e-05	8.73e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.13e-05	8.71e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.03e-05	8.3e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.78e-05	7.3e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAV1—ovarian cancer	1.72e-05	7.03e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.57e-05	6.41e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.55e-05	6.36e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.38e-05	5.63e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTEN—ovarian cancer	1.34e-05	5.5e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.2e-05	4.91e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTEN—ovarian cancer	1.04e-05	4.24e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CA—ovarian cancer	9.48e-06	3.88e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—ovarian cancer	7.74e-06	3.17e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.32e-06	2.99e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—ovarian cancer	5.98e-06	2.44e-05	CbGpPWpGaD
